{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:56:57Z","timestamp":1776884217539,"version":"3.51.2"},"reference-count":18,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n In preterm neonates supported with continuous positive airway pressure (CPAP), early caffeine administration and less invasive surfactant administration (LISA) results in a lower frequency of endotracheal intubation. It is unknown whether this regimen improves outcomes at a corrected age of 2 years in this population.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether LISA improves neurodevelopmental impairment (NDI) and pulmonary outcomes at a corrected age of 2 years.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This prespecified secondary analysis and follow-up of a randomized clinical trial was performed at 3 academic medical centers in California. Participants included infants born at gestational ages ranging from 24 weeks 0 days to 29 weeks 6 days with follow-up assessments available. Follow-up visits occurred from May 2, 2022, to April 3, 2025.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Infants received intravenous caffeine by 2 hours of life followed by either less invasive surfactant administration (intervention group) or CPAP without initial surfactant administration (control group).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the composite of death or moderate to severe NDI at a corrected age of 2 years, as measured by the Bayley Scales of Infant Development (BSID). Secondary outcomes included components of the BSID composite; the third edition of the Ages and Stages Questionnaire (ASQ-3); developmental screening; pulmonary outcomes of bronchodilator use, oral and\/or inhaled corticosteroid use, or hospitalizations with respiratory diagnoses after discharge; and results of an autism screen.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 180 randomized infants, 147 (81.7%) had follow-up assessments available (74 in the LISA group and 73 in the CPAP group); 75 infants (51.0%) were male. The mean (SD) gestational age at the time of the Bayley assessment was 24.6 (1.5) months corrected age for the LISA group and 24.7 (2.2) months corrected age for the CPAP group. The mean (SD) chronological age for the ASQ-3 was 28.1 (2.4) months for both groups. Death or moderate to severe NDI occurred in 17 of 74 children (23.0%) in the LISA group and 23 of 70 (32.9%) in the control group (odds ratio [OR], 1.56 [95% CI, 0.77-3.17];\n P<\/jats:italic>\n \u2009=\u2009.22). On the screening ASQ-3, infants in the LISA group had no statistically significant differences in rates of typical development (22 of 69 [31.9%] vs 12 of 67 [17.9%]; OR, 0.47 [95% CI, 0.21-1.04];\n P<\/jats:italic>\n \u2009=\u2009.06) and scores indicating possible delay (43 of 69 [62.3%] vs 47 of 67 [70.1%]; OR, 1.42 [95% CI, 0.70-2.90];\n P<\/jats:italic>\n \u2009=\u2009.34) compared with the control group. Children in the LISA group were more likely to have a mean (SD) fine motor\n z<\/jats:italic>\n score in the reference range (\u22120.59\u2009[1.10] vs \u22121.00\u2009[1.01];\n P<\/jats:italic>\n \u2009=\u2009.03). There were no differences between the LISA and CPAP groups in bronchodilator use, oral and\/or inhaled corticosteroid use, or postdischarge hospitalizations with respiratory diagnoses.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this secondary analysis of a randomized clinical trial of preterm infants supported with CPAP, early caffeine administration plus LISA did not reduce the incidence of death or moderate to severe NDI noted on the BSID. Infants who received LISA were more likely to have a fine motor domain score in the reference range on ASQ-3 developmental screen.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04209946<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.3852","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:30:26Z","timestamp":1774971026000},"page":"e263852","source":"Crossref","is-referenced-by-count":0,"title":["Two-Year Outcomes of Less Invasive Surfactant Administration Among Preterm Neonates"],"prefix":"10.1001","volume":"9","author":[{"given":"Rebecca A.","family":"Dorner","sequence":"first","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Morales","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamika","family":"Banerji","sequence":"additional","affiliation":[{"name":"Loma Linda University Children\u2019s Hospital, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherry","family":"Uy","sequence":"additional","affiliation":[{"name":"University of California Irvine Medical Center, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Ines","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Finer","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Vaucher","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup C.","family":"Katheria","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"5","key":"zoi260153r1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011672.pub2","article-title":"Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.","volume":"5","author":"Abdel-Latif","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"zoi260153r2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamapediatrics.2015.0504","article-title":"Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial.","volume":"169","author":"Kribs","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"3","key":"zoi260153r3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/apa.15565","article-title":"Developmental outcome of extremely preterm infants is improved after less invasive surfactant application: developmental outcome after LISA.","volume":"110","author":"Mehler","year":"2021","journal-title":"Acta Paediatr"},{"issue":"11","key":"zoi260153r4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/jama.2023.15694","article-title":"Two-year outcomes after minimally invasive surfactant therapy in preterm infants: follow-Up of the OPTIMIST-A randomized clinical trial.","volume":"330","author":"Dargaville","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"zoi260153r5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/pr.2017.45","article-title":"Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial.","volume":"82","author":"Dekker","year":"2017","journal-title":"Pediatr Res"},{"key":"zoi260153r6","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300183","article-title":"Caffeine and less invasive surfactant administration for respiratory distress syndrome of the newborn.","author":"Katheria","year":"2023","journal-title":"NEJM Evid"},{"issue":"4","key":"zoi260153r7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5409\/wjcp.v4.i4.81","article-title":"Caffeine therapy in preterm infants.","volume":"4","author":"Abdel-Hady","year":"2015","journal-title":"World J Clin Pediatr"},{"issue":"6","key":"zoi260153r8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamapediatrics.2017.0238","article-title":"Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial.","volume":"171","author":"Schmidt","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"10","key":"zoi260153r9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1164\/rccm.201704-0767OC","article-title":"Neonatal caffeine treatment and respiratory function at 11 years in children under 1,251 g at birth.","volume":"196","author":"Doyle","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"zoi260153r10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jamapediatrics.2022.3079","article-title":"Utility of the ages and stages questionnaire to identify developmental delay in children aged 12 to 60 months: a systematic review and meta-analysis.","volume":"176","author":"Muthusamy","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"6","key":"zoi260153r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.6757","article-title":"Racial\/ethnic disparities among extremely preterm infants in the United States from 2002 to 2016.","volume":"3","author":"Travers","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi260153r13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dmcn.12297","article-title":"Development of fine motor skills in preterm infants.","volume":"55","author":"Bos","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"zoi260153r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2020.101109","article-title":"International comparisons of neurodevelopmental outcomes in infants born very preterm.","volume":"25","author":"Torchin","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"zoi260153r15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41390-023-02528-y","article-title":"ASQ-3 and BSID-III\u2019s concurrent validity and predictive ability of cognitive outcome at 5 years.","volume":"94","author":"Duggan","year":"2023","journal-title":"Pediatr Res"},{"issue":"5","key":"zoi260153r16","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41390-022-02265-8","article-title":"Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?","volume":"93","author":"Kakkilaya","year":"2023","journal-title":"Pediatr Res"},{"key":"zoi260153r17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpeds.2016.06.051","article-title":"Intubation attempts increase the risk for severe intraventricular hemorrhage in preterm infants\u2013a retrospective cohort study.","volume":"177","author":"Sauer","year":"2016","journal-title":"J Pediatr"},{"issue":"3","key":"zoi260153r18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.2009-2863","article-title":"Premedication for nonemergency endotracheal intubation in the neonate.","volume":"125","author":"Kumar","year":"2010","journal-title":"Pediatrics"},{"key":"zoi260153r11","volume-title":"Ages & Stages Questionnaires: A Parent-Completed Child-Monitoring System","author":"Squires","year":"2009","edition":"3rd ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847138\/dorner_2026_oi_260153_1776882207.43895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:30:16Z","timestamp":1776882616000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847138"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.3852","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}